Form 4: GoodRx Holdings Executive Romin Nabiey Reports Stock Transactions
SEC Form 4 Filing
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the vesting and subsequent disposal of Class A Common Stock to cover tax obligations.
Summary
- On August 8, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock.
- 12,663 shares were acquired through the vesting of restricted stock units.
- 4,519 shares were disposed of to satisfy tax withholding obligations at a price of $8.61 per share.
- Following these transactions, Nabiey directly owns 143,633 shares of Class A Common Stock and 139,290 restricted stock units.
- The restricted stock units vest in quarterly installments.
Sentiment
Score: 5
Explanation: This is a routine filing reflecting standard executive compensation practices; it doesn't indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 08/08/2023 | 6.25% of the restricted stock units vested |
| 08/08/2024 | Date of stock transactions: vesting of 12,663 shares and disposal of 4,519 shares for tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.